Paul G Thomas Selected Research

Paul G Thomas Research Topics

Disease

64	Infections 12/2022 - 04/2005
44	Human Influenza (Influenza) 01/2022 - 01/2006
20	Neoplasms (Cancer) 10/2022 - 12/2010
12	COVID-19 12/2022 - 05/2020
10	Inflammation (Inflammations) 01/2022 - 07/2013
10	Virus Diseases (Viral Diseases) 11/2021 - 05/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2019
5	Pneumonia (Pneumonitis) 12/2019 - 09/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2017
3	Cytokine Release Syndrome 12/2020 - 01/2017
2	Breakthrough Infections 01/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2016
2	Residual Neoplasm 01/2021 - 01/2019
2	Leukemia 01/2020 - 01/2015
2	Persistent Infection 12/2018 - 06/2017
2	Communicable Diseases (Infectious Diseases) 12/2018 - 01/2016
2	Lung Injury 01/2018 - 01/2016
2	Coinfection 01/2017 - 03/2014
2	Respiratory Syncytial Virus Infections 12/2011 - 02/2011
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Lung Diseases (Lung Disease) 10/2022
1	Reinfection 01/2022
1	Hepatitis B 01/2022
1	Carcinogenesis 01/2022
1	Neuroblastoma 11/2021
1	Convalescence 11/2021
1	Vesicular Stomatitis 10/2021
1	Berylliosis 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Respiratory Insufficiency (Respiratory Failure) 05/2020

Drug/Important Bio-Agent (IBA)

20	EpitopesIBA 01/2022 - 03/2007
19	AntigensIBA 10/2022 - 02/2009
18	CytokinesIBA 01/2022 - 03/2007
17	VaccinesIBA 10/2022 - 04/2005
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2006
9	AntibodiesIBA 12/2022 - 01/2014
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 02/2011
7	Peptides (Polypeptides)IBA 11/2021 - 01/2006
6	ChemokinesIBA 01/2022 - 03/2009
5	ImmunosorbentsIBA 05/2022 - 01/2014
5	EnzymesIBA 05/2022 - 01/2014
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
5	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 10/2015 - 03/2007
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2013
4	InterferonsIBA 12/2020 - 04/2006
4	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2016
3	Immunoglobulin A (IgA)IBA 05/2022 - 01/2014
3	Messenger RNA (mRNA)IBA 05/2022 - 09/2021
3	Immunoglobulin G (IgG)IBA 05/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2010
3	Amino Acids FDA Link 11/2021 - 01/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2020
3	Oseltamivir (Tamiflu)FDA Link 12/2019 - 01/2015
3	Histones (Histone)IBA 12/2019 - 11/2014
2	Indicators and Reagents (Reagents)IBA 12/2022 - 07/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	mRNA VaccinesIBA 01/2022 - 01/2022
2	Monoclonal AntibodiesIBA 09/2021 - 07/2008
2	Viral AntigensIBA 01/2021 - 11/2014
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2020 - 05/2020
2	Peptide Hydrolases (Proteases)FDA Link 11/2020 - 02/2014
2	Histocompatibility Antigens Class IIBA 10/2020 - 12/2010
2	Interferon-gamma (Interferon, gamma)IBA 05/2020 - 12/2014
2	NucleoproteinsIBA 01/2019 - 01/2013
2	AcidsIBA 01/2019 - 01/2013
2	Phospholipase DIBA 05/2017 - 09/2014
2	LipidsIBA 05/2017 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2015 - 12/2013
2	1-dodecylpyridoxal (PLD)IBA 12/2014 - 09/2014
2	Phosphotransferases (Kinase)IBA 12/2013 - 05/2013
1	Chimeric Antigen ReceptorsIBA 11/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	CBLC137IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	RNA Splicing FactorsIBA 11/2021
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 11/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021
1	RNA Precursors (Precursor, mRNA)IBA 11/2021
1	Arginine (L-Arginine)FDA Link 10/2021
1	2-mercaptopurineIBA 01/2021
1	blinatumomabIBA 01/2021
1	BerylliumIBA 01/2021
1	NucleosidesIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	GlucocorticoidsIBA 05/2020
1	SqualeneIBA 01/2020
1	Interleukin-12 Subunit p40IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020

Therapy/Procedure

12	Therapeutics 10/2022 - 03/2014
8	Immunotherapy 01/2020 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2020
1	Contraindications 01/2020